[go: up one dir, main page]

DK0807173T3 - Fremgangsmåder til fremstilling af immunoglobuliner indeholdende beskyttelsesproteiner i planter og anvendelse deraf - Google Patents

Fremgangsmåder til fremstilling af immunoglobuliner indeholdende beskyttelsesproteiner i planter og anvendelse deraf

Info

Publication number
DK0807173T3
DK0807173T3 DK95944237T DK95944237T DK0807173T3 DK 0807173 T3 DK0807173 T3 DK 0807173T3 DK 95944237 T DK95944237 T DK 95944237T DK 95944237 T DK95944237 T DK 95944237T DK 0807173 T3 DK0807173 T3 DK 0807173T3
Authority
DK
Denmark
Prior art keywords
immunoglobulins
plants
preparation
methods
pathogens
Prior art date
Application number
DK95944237T
Other languages
English (en)
Inventor
Andrew C Hiatt
Julian K-C Ma
Thomas Lehner
Keith E Mostov
Original Assignee
Univ California
Planet Biotechnology Inc
King S College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/434,000 external-priority patent/US6046037A/en
Application filed by Univ California, Planet Biotechnology Inc, King S College London filed Critical Univ California
Application granted granted Critical
Publication of DK0807173T3 publication Critical patent/DK0807173T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
DK95944237T 1994-12-30 1995-12-27 Fremgangsmåder til fremstilling af immunoglobuliner indeholdende beskyttelsesproteiner i planter og anvendelse deraf DK0807173T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36739594A 1994-12-30 1994-12-30
US08/434,000 US6046037A (en) 1994-12-30 1995-05-04 Method for producing immunoglobulins containing protection proteins in plants and their use
PCT/US1995/016889 WO1996021012A1 (en) 1994-12-30 1995-12-27 Methods for producing immunoglobulins containing protection proteins in plants and their use

Publications (1)

Publication Number Publication Date
DK0807173T3 true DK0807173T3 (da) 2008-01-07

Family

ID=27003775

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95944237T DK0807173T3 (da) 1994-12-30 1995-12-27 Fremgangsmåder til fremstilling af immunoglobuliner indeholdende beskyttelsesproteiner i planter og anvendelse deraf

Country Status (11)

Country Link
US (2) US6303341B1 (da)
EP (2) EP0807173B1 (da)
JP (1) JPH11504901A (da)
CN (1) CN1183802A (da)
AT (1) ATE369423T1 (da)
AU (1) AU722668B2 (da)
CA (1) CA2208783C (da)
DE (1) DE69535557T2 (da)
DK (1) DK0807173T3 (da)
ES (1) ES2292173T3 (da)
WO (1) WO1996021012A1 (da)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5959177A (en) * 1989-10-27 1999-09-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
US7005560B1 (en) * 1989-10-27 2006-02-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
US6808709B1 (en) 1994-12-30 2004-10-26 The Regents Of The University Of California Immunoglobulins containing protection proteins and their use
US5990385A (en) * 1997-11-10 1999-11-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food Protein production in transgenic alfalfa plants
AU3115299A (en) * 1998-03-25 1999-10-18 Planet Biotechnology, Inc. Methods and compositions for production of multimeric proteins in transgenic plants
US7485715B2 (en) * 1999-06-18 2009-02-03 Ceres, Inc. Sequence-determined DNA encoding AP2 domain polypeptides
US7479555B2 (en) * 1999-07-21 2009-01-20 Ceres, Inc. Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity
WO2001072846A2 (en) * 2000-03-27 2001-10-04 The Regents Of The University Of California Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof
US20060015969A1 (en) * 2000-04-28 2006-01-19 Planet Biotechnology, Inc. Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases
ES2332872T3 (es) 2000-04-28 2010-02-15 Planet Biotechnology, Inc. Inmunoadhesina para la prevencion de la infeccion por rinovirus.
US6696620B2 (en) * 2000-05-02 2004-02-24 Epicyte Pharmaceutical, Inc. Immunoglobulin binding protein arrays in eukaryotic cells
US7304208B2 (en) * 2000-05-02 2007-12-04 Ventria Bioscience Expression of human serum albumin (HSA) in monocot seeds
WO2002015931A1 (en) * 2000-08-24 2002-02-28 Washington Dental Service Immunologic method for the prevention of dental caries
CA2451863A1 (en) * 2001-06-15 2002-12-27 The University Of Toledo Method for transformation of mono- and di- cotyledonous plants using meristematic tissue and nodal callus from dycotiledonous plants
US20070118934A1 (en) * 2001-10-26 2007-05-24 Planet Biotechnology, Inc. Chimeric toxin receptor proteins and chimeric toxin receptor proteins for treatment and prevention of anthrax
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
SI1523496T1 (sl) * 2002-07-18 2011-11-30 Merus B V Rekombinantno proizvajanje zmesi protiteles
WO2004027038A2 (en) * 2002-09-17 2004-04-01 Ceres, Inc. Biological containment system
US7476777B2 (en) * 2002-09-17 2009-01-13 Ceres, Inc. Biological containment system
EP2395017A3 (en) 2003-05-30 2012-12-19 Merus B.V. Design and use of paired variable regions of specific binding molecules
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
US20050138692A1 (en) * 2003-06-02 2005-06-23 Biotechnology Foundation, Inc. Production of cancer-specific antibodies in plants
WO2005056578A2 (en) * 2003-12-09 2005-06-23 Ventria Bioscience High-level expression of fusion polypeptides in plant seeds utilizing seed-storage proteins as fusion carriers
WO2005067699A1 (en) * 2003-12-23 2005-07-28 Ventria Bioscience Methods of expressing heterologous protein in plant seeds using monocot non seed-storage protein promoters
EP1737971B1 (en) 2004-01-20 2017-08-16 Merus N.V. Mixtures of binding proteins
US9758790B2 (en) 2004-12-08 2017-09-12 Ceres, Inc. Modulating the level of components within plants
WO2007050625A1 (en) * 2005-10-25 2007-05-03 Ceres, Inc. Modulation of triterpenoid content in plants
AU2006216715A1 (en) * 2005-02-22 2006-08-31 Ceres Inc. Modulating plant alkaloids
WO2006115575A1 (en) * 2005-04-20 2006-11-02 Ceres Inc. Regulatory regions from papaveraceae
US8124839B2 (en) * 2005-06-08 2012-02-28 Ceres, Inc. Identification of terpenoid-biosynthesis related regulatory protein-regulatory region associations
ES2426194T3 (es) * 2005-08-02 2013-10-21 Planet Biotechnology, Inc. Proteínas quiméricas del receptor de toxina mejoradas y proteínas quiméricas del receptor de toxina para el tratamiento y la prevención de anthrax
US20100062137A1 (en) * 2005-09-30 2010-03-11 Steven Craig Bobzin Modulating plant tocopherol levels
US20070199090A1 (en) * 2006-02-22 2007-08-23 Nestor Apuya Modulating alkaloid biosynthesis
WO2007117693A2 (en) * 2006-04-07 2007-10-18 Ceres, Inc. Regulatory protein-regulatory region associations related to alkaloid biosynthesis
US10328103B2 (en) 2009-01-03 2019-06-25 Ray C. Wasielewski Medical treatment composition comprising mammalian dental pulp stem cells
US8470308B2 (en) * 2009-01-03 2013-06-25 Ray C. Wasielewski Enhanced medical implant comprising disrupted tooth pulp and tooth particles
ES2743399T3 (es) 2012-04-20 2020-02-19 Merus Nv Métodos y medios para la producción de moléculas heterodiméricas similares a Ig
PL3489261T3 (pl) 2012-08-24 2021-08-16 The Regents Of The University Of California Przeciwciała i szczepionki do stosowania w leczeniu nowotworów z ekspresją ROR1 i w hamowaniu przerzutu
EP2762496A1 (en) 2013-02-05 2014-08-06 EngMab AG Method for the selection of antibodies against BCMA
PL2953972T3 (pl) 2013-02-05 2021-03-08 Engmab Sàrl Metoda wyboru przeciwciał przeciwko bcma
WO2014124457A1 (en) * 2013-02-11 2014-08-14 University Of Louisville Research Foundation, Inc. Methods for producing antibodies
EP2789630A1 (en) 2013-04-09 2014-10-15 EngMab AG Bispecific antibodies against CD3e and ROR1
EP3204415B1 (en) 2014-10-09 2020-06-17 EngMab Sàrl Bispecific antibodies against cd3epsilon and ror1
PT3331910T (pt) 2015-08-03 2020-03-24 Engmab Sarl Anticorpos monoclonais contra o antigénio de maturação de células b (bcma) humano
CA3029003A1 (en) 2016-06-27 2018-01-04 The Regents Of The University Of California Cancer treatment combinations
US11124577B2 (en) 2016-11-02 2021-09-21 Engmab Sàrl Bispecific antibody against BCMA and CD3 and an immunological drug for combined use in treating multiple myeloma
EP3846840A4 (en) * 2018-09-05 2022-06-15 Ventria Bioscience Inc. Formulations of immunoglobulin a
CA3118692A1 (en) 2018-11-06 2020-05-14 Alsatech, Inc. Cell-based gene therapy for neurodegenerative diseases
US12343375B2 (en) 2021-02-09 2025-07-01 University Of Louisville Research Foundation, Inc. Spray dried formulation of a cholera toxin B subunit variant
CN113875778A (zh) * 2021-09-29 2022-01-04 季红进 含有植物免疫活性蛋白和5-氨基乙酰丙酸或其衍生物的生物刺激剂

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4443549A (en) 1981-10-19 1984-04-17 Molecular Genetics, Inc. Production of monoclonal antibodies against bacterial adhesins
US4652448A (en) 1982-10-07 1987-03-24 Molecular Genetics, Inc. Use of monoclonal antibodies against bacterial adhesins
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US5034322A (en) 1983-01-17 1991-07-23 Monsanto Company Chimeric genes suitable for expression in plant cells
US5352605A (en) 1983-01-17 1994-10-04 Monsanto Company Chimeric genes for transforming plant cells using viral promoters
GB8303994D0 (en) 1983-02-14 1983-03-16 Council Of Governors Of United Antigenic materials
FI68590C (fi) 1984-03-15 1985-10-10 Rosenlew Ab Oy W Flexibel behaollare foer transport och lagring av massagods
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
EP0229174A1 (en) 1985-07-16 1987-07-22 The Salk Institute For Biological Studies Genetic alteration of plants with retroviruses
CA1313830C (en) 1985-08-07 1993-02-23 Dilip Maganlal Shah Glyphosate-resistant plants
US5352446A (en) 1986-03-25 1994-10-04 Council Of Governors Of The United Medical And Dental Schools Of Guy's And St. Thomas's Hospitals Method of treating dental caries with monoclonal antibodies against the antigen I and antigen I/II of streptococcus mutans
GB8704648D0 (en) 1987-02-27 1987-04-01 Guy S & St Thomas S Hospitals Antibodies
US5352440A (en) 1988-03-30 1994-10-04 Trustees Of Boston University Methods for increasing melanin content in melanocytes using diacylglycerols and uses thereof
ES2077589T3 (es) 1988-04-25 1995-12-01 Monsanto Co Plantas de lechuga resistentes a insectos.
US5183756A (en) 1988-08-19 1993-02-02 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibody (D612) having selective reactivity for gastrointestinal caricinomas and method for employing the same
CA2016842A1 (en) 1989-05-16 1990-11-16 Richard A. Lerner Method for tapping the immunological repertoire
US5959177A (en) 1989-10-27 1999-09-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
US5202422A (en) 1989-10-27 1993-04-13 The Scripps Research Institute Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use
CN1057785A (zh) * 1990-04-16 1992-01-15 哈佛大学校长及研究员协会 合成多聚免疫球蛋白受体,受体-抗体复合物,生产及应用
JPH04169539A (ja) 1990-11-01 1992-06-17 Imuno Japan:Kk 消化器疾患治療・予防剤およびその製造方法

Also Published As

Publication number Publication date
EP0807173B1 (en) 2007-08-08
WO1996021012A1 (en) 1996-07-11
CN1183802A (zh) 1998-06-03
DE69535557D1 (de) 2007-09-20
DE69535557T2 (de) 2008-04-30
US6303341B1 (en) 2001-10-16
AU722668B2 (en) 2000-08-10
ES2292173T3 (es) 2008-03-01
ATE369423T1 (de) 2007-08-15
JPH11504901A (ja) 1999-05-11
EP0807173A1 (en) 1997-11-19
CA2208783A1 (en) 1996-07-11
AU4608896A (en) 1996-07-24
EP1911767A3 (en) 2008-09-10
US20020159958A1 (en) 2002-10-31
CA2208783C (en) 2010-09-28
EP1911767A2 (en) 2008-04-16

Similar Documents

Publication Publication Date Title
DK0807173T3 (da) Fremgangsmåder til fremstilling af immunoglobuliner indeholdende beskyttelsesproteiner i planter og anvendelse deraf
ATE298792T1 (de) Pflanzenwuchserhöhung
BR9104965A (pt) Proteina de tabaco,processo para purificar putrescina n-metiltransferase de um extrato de planta de tabaco,moleculas de dna recombinante,vetor,celula de tabaco transgenica cultivada e planta de tabaco
EP0842285A4 (en) Root cortex specific gene promoter
DK240088D0 (da) Fremgangsmaade til transformation af et plantecellematerale
ATE5821T1 (de) N-phosphonomethylglyzin-trialkylsulfoxoniumsalz , ihre herstellung und ihre verwendung als pflanzenwachstumsregulatoren und herbizide und sie enthaltende zusammensetzungen.
DK0699755T3 (da) Fremgangsmåde til opnåelse af modificerede immunglobuliner med reduceret immunogenicitet af variable domæner i et murint antistof, præparater der indeholder disse
CY1108477T1 (el) Μεθοδοι για την παραγωγη ινσουλινης σε φυτα
DK1005529T3 (da) Fremgangsmåder til lyofilisering af kompetente celler
DK0700995T3 (da) Fremgangsmåde til fremstilling af protein
DE69808012D1 (de) Bei Raumtemperatur lagerfähiges Immunoglobolin-Präparat für intravenöse Injektion
AR008286A1 (es) Molecula de acido nucleico aislada, vector, celula, planta transgenica que la incluyen, semilla y celula de dicha planta, polipeptido de resistenciaadquirida codificado por dicha molecula, metodo para producir dicho polipeptido, anticuerpo substancialmente puro que se liga a dicho polipeptido y
NO930317L (no) Fremgangsmåte og anlegg for utnyttelse henholdsvis tilveiebringelse av brenngass
DE59912361D1 (de) 2,4-diamino-1,3,5-triazine, verfahren zur herstellung und verwendung als herbizide und pflanzenwachstumsregulatoren
DK1290027T3 (da) Immunoadhæsin til forebyggelse af rhinovirusinfektion
HK1044956A1 (zh) 重組細胞聚變份子
BG41993A3 (en) Means and method for increase in cold resistance of plant cultures
NO854854L (no) Fremgangsmaate for kvalitativ og kvantitativ forbedring av bladgjoedsling av nytte- og prydplanter i veksthus, paa friland eller ved aakerbruk.
DK0546087T3 (da) Proteinstruktur af plantetoksinet gelonin
RU94045821A (ru) Трансгенные растения, проявляющие множественную устойчивость к вирусу, и способ их получения
Schmitt et al. Biochemical response of Norway spruce (Picea abies (L.) Karst.) towards 14-month exposure to ozone and acid mist: Part II—effects on protein biosynthesis
DK0658626T3 (da) Fremgangsmåder til produktion af protein C
DE60234377D1 (de) Stress-assoziierte, protein kinase-spezifische polypeptide und verfahren zur verwendung in pflanzen
DE59503620D1 (de) Formylaminophenylsulfonylharnstoffe, verfahren zur herstellung und verwendung als herbizide und pflanzenwachstumsregulatoren
DK0671121T3 (da) Hybriddyrkningsfremgangsmåder for kulturplanter i familien Brasicaceae